SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019687-14-000409
Filing Date
2014-02-06
Accepted
2014-02-06 17:10:12
Documents
1
Period of Report
2014-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 jafco_frm3.html 3  
1 FORM 3 jafco_frm3.xml 3 6803
  Complete submission text file 0001019687-14-000409.txt   8502
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004
Business Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004 81-3-5223-7008
JAFCO Super V3 Investment Limited Partnership (Reporting) CIK: 0001590442 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 14580971